Company news

Pasithea Therapeutics Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada

November 30, 2021

Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules

November 23, 2021

Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.

November 22, 2021

Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint

November 16, 2021

Pasithea Therapeutics Corp. Establishes Scientific Advisory Board and Names Dr. Charles B. Nemeroff as Chair

November 8, 2021

Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy

October 26, 2021

Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom

October 13, 2021

Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

October 10, 2021

Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering

September 16, 2021

← Newer news releases

Decks